Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Laboratory Partners & Hospitals Revenue by Year
Laboratory Partners & Hospitals Revenue — Institutional Payers ($M) ($M)
Natera Laboratory Partners & Hospitals Revenue: $103M in FY2025, up 6.1% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Revenue from domestic and international laboratory distribution partners, hospital systems, and biopharma research partners.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Laboratory Partners & Hospitals Revenue — Institutional Payers ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 103 | +6.1% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 97.2 | -1.7% | Form 10-K (2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 98.9 | +4.2% | Form 10-K (2026-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 94.9 | -5.1% | Form 10-K (2025-02-28) ↗ |
| FY2021 | Dec 31, 2021 | 100 | +71.9% | Form 10-K (2024-02-29) ↗ |
| FY2020 | Dec 31, 2020 | 58.2 | -2.8% | Form 10-K (2023-03-01) ↗ |
| FY2019 | Dec 31, 2019 | 59.9 | +35.9% | Form 10-K (2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 44.1 | +22.4% | Form 10-K (2021-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 36 | -22.0% | Form 10-K (2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | 46.1 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Laboratory Partners & Hospitals Revenue ($M), annual FY2016–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-payer-lab-partners
See every metric in the Natera KPI table. Data updated Nov 2, 2026.